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Available online 24 October 2016In our mouse model, gastric acid-suppression is associated with antigen-speciﬁc IgE and anaphylaxis develop-
ment. We repeatedly observed non-responder animals protected from food allergy. Here, we aimed to analyse
reasons for this protection. Ten out of 64 mice, subjected to oral ovalbumin (OVA) immunizations under gastric
acid-suppression, were non-responders without OVA-speciﬁc IgE or IgG1 elevation, indicating protection
from allergy. In these non-responders, allergen challenges conﬁrmed reduced antigen uptake and lack of anaphy-
lactic symptoms, while in allergicmice high levels of mousemast-cell protease-1 and a body temperature reduc-
tion, indicative for anaphylaxis, were determined. Upon OVA stimulation, signiﬁcantly lower IL-4, IL-5, IL-10 and
IL-13 levels were detected in non-responders, while IL-22 was signiﬁcantly higher. Comparison of fecal microbi-
ota revealed differences of bacterial communities on single bacterial Operational-Taxonomic-Unit level between
the groups, indicating protection from food allergy being associated with a distinct microbiota composition in a
non-responding phenotype in this mouse model.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/4.0/).Keywords:
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Severity and unpredictability of clinical reactions in context with
food allergy are major challenges for patients, caretakers and healthPI, protonpump inhibitor; OC,
se-1; i.g., intragastric; TMB,
riodic acid-Schiff reagent; CAE,
ine, Messerli Research Institute
rsity of Vienna, University of
Pathophysiology and Allergy
munology, Medical University
i-Schöll),
. This is an open access article undercare personnel. The observed clinical response might differ between
food allergic patients ranging frommild local symptoms like the oral al-
lergy syndrome to severe systemic reactions such as anaphylaxis [1,2].
Actually, food allergy is among the main causes for potentially life-
threatening anaphylaxis accounting for 41% of fatal reactions as re-
ported to an European anaphylaxis registry [3]. For an efﬁcient deﬁni-
tion of allergy prevention measures, a profound mechanistic
knowledge on sensitizing events is fundamental.
During the past years, we have investigated the association between
anti-ulcer drug intake and food allergy development [4–10]. In ﬁrst
human studies in adult patients, a 3 months treatment with anti-ulcer
drugs led to an increase of pre-existing food-speciﬁc IgE titers in 10%
of patients, and to de novo sensitization against common dietary com-
pounds in 15% of patients [8]. Among them, in 60% of patients with
hazelnut-speciﬁc IgE clinically relevant food allergy was diagnosed by
double-blind placebo controlled food challenges [10]. Further studiesthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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during pregnancy or anti-ulcer drug treatment of pediatric patients on
the development of food allergy also in children [7,11–14].
Based on these murine and human data, a mouse model of oral
sensitization under concomitant acid-suppression was developed
being associated with induction of allergen-speciﬁc IgE, elevated Th2
cytokines and positive skin tests [5]. This immunization protocol
induced severe clinical responses evidenced by positive mucosal
testing, a drop of body temperature after provocations and a sustained
mediator release [5,6,9].
However, in both, human and experimental studies, a certain
percentage of individuals is protected from food allergy development
during intake of anti-ulcer medication. This heterogeneity of reactivity
especially in experimental studies with inbred mouse strains has been
a matter of debate. To gain novel mechanistic insights, the overall aim
of the current study was to phenotype those mice being protected
from food allergy development (non-responders) in comparison with
animals revealingmarked systemic food allergic symptoms after immu-
nizations based on our experimental food allergy protocol.
2. Material and methods
2.1. Animals and immunization regimen
Sixty-four female BALB/cAnNCrl mice (aged 6–8 weeks, 15–20 g)
were purchased from Charles River Laboratory (Charles River Labora-
tory, Sulzfeld, Germany). Mice were kept in polycarbonate Makrolon
cages (Ehret GmbH, Emmendingen, Germany) with ﬁlter tops and
espen wood bedding (Ehret GmbH, Emmendingen, Germany) and
housed under conventional conditions (12 h light/dark cycle at 22 °C).
The animals were kept on an ovalbumin (OVA) free diet (Ssniff, Soest,
Germany) with ad libitum access to food and water. Treatment of the
animals was performed by trained staff in the morning in an animal
experimentation room. Animals were treated according to European
Union guidelines of animal care and with permission of the ethical
board of the Medical University of Vienna and the Austrian Federal
Ministry of Science and Research (permission number GZ BMWF-
66.009/0051-II/10b/2008). All animalswere subjected to our previously
established food allergy protocol [5] with modiﬁcation. On days 1 to 3,
animals were treated intravenously (i.v.) with the proton pump inhibi-
tor (PPI; Losec® Astra Zeneca GmbH,Wedel, Germany; 116 μg omepra-
zole in 100 μL sterile sodium chloride) 2 timeswithin 1 h. On days 2 and
3, mice were fed 0.2 mg OVA (Sigma Aldrich, Vienna, Austria, #A5503)
in combination with sucralfate (2 mg; Ulcogant®, Merck, Vienna,
Austria) 15 min after the second PPI i.v. injection. This immunizationFig. 1. Immunization scheme and selection of animals. Sixty-four BALB/c mice were immunized
OVA-speciﬁc IgE and IgG1 antibodies, 10 animals were selected as the group of interest (non-re
characterized as being anaphylactic during the study evaluations (group A). IMM, immunizatiocycle was repeated for 7 times (Fig. 1A). Out of the total of 64 animals
undergoing the immunization protocol, we deﬁned 10 animals of inter-
est based on their IgE and IgG1 antibody titers after the last immuniza-
tion step. These ten mice revealed antibody levels below the detection
limit and were classiﬁed as antibody non-responder group (group N,
n = 10/64; Fig. 1B). They were compared to 10 control animals with
an OVA-speciﬁc IgE antibody response above 15 ng/mL classiﬁed as
highly sensitized (allergic) group (group A; n = 10/64). This cut-off
level was chosen based on our numerous previous immunization
studies investigating clinical response upon oral immunizations under
gastric acid suppression [5,6,9] and own unpublished data. All other
sensitized animals with IgE responses below 15 ng/mL and above back-
ground values aswell asOVA-speciﬁc IgG1 responses (n=44)were ex-
cluded from this study. Four weeks after the last immunization, mice
were subjected to an oral PBS challenge for control purposes to exclude
unspeciﬁc changes during provocation and 10 days later to an oral OVA
provocation (50 mg per mouse; oral challenge 1 (OC1)). Mice were
fasted overnight before oral challenges with access to water only. One
hour after each challenge, blood was collected for measurements of
mouse mast cell protease-1 (mMCP-1) as well as OVA uptake. Four
days thereafter, animals were re-challenged with OVA i.g. (OC2) to
induce a strong local intestinal allergic response. One hour later, mice
were challenged i.v. (50 μgOVA in 50 μL 0.9% sodiumchloride) to trigger
a systemic anaphylactic response. Mice were sacriﬁced 15 min
thereafter.
Blood samples were taken prior to the ﬁrst immunization step and
2 weeks after the last immunization, 1 h after the PBS challenge as
well as after the ﬁrst OVA challenge (OC1).
2.2. Antibody measurements
Mouse sera were collected before the ﬁrst and 2 weeks after the last
immunization step and screened for OVA-speciﬁc IgE, IgG1, IgG2a and
IgA in ELISA, as described recently [5] using rat anti-mouse IgG1,
IgG2a, IgA and IgE (0.1 μg per well, BD Biosciences, Heidelberg,
Germany) and peroxidase-labeled goat anti-rat IgG (1:1000,
Amersham, Buckinghamshire, UK). After sacriﬁce, mouse intestines
were removed and ﬂushed with 2 mL extraction buffer (Complete
Mini, Roche) for detection of mucosal total and OVA-speciﬁc IgA levels.
For total IgA determination, microtiter plates were coated with a rat
anti-mouse IgA (0.1 μg per well; BD Biosciences) overnight at 4 °C.
After washing, wells were blocked with 1% bovine serum albumin in
TBS containing 0.05% Tween for 2 h. Thereafter, standard dilution series
or mucosal lavage ﬂuid (diluted 1:1000) were added for 30 min. After
repeated washing, a biotin-labeled anti-mouse IgA antibody (0.1 μg(panel A) according to the protocol described in themethods section. Based on the lack of
sponder, group N; panel B). They were compared to highly sensitized animals, whichwere
n; MIS, mouse immune serum; OC, oral OVA challenge; i.v. C., intravenous challenge.
Fig. 2. OVA-speciﬁc antibody proﬁle in murine sera. OVA-speciﬁc IgE (A), IgG1 (B), IgG2a (C) and IgA (D) levels were determined by ELISA. According to the serological status, animals of
interest were selected as antibody non-responders (group N) and compared to highly sensitized control animals (group A). Data represent mean + standard error of the mean (SEM);
****p b 0.0001, ***p b 0.001, **p b 0.01.
12 S.C. Diesner et al. / Clinical Immunology 173 (2016) 10–18per well; BD Biosciences) was added for 30 min. After washing, wells
were incubated with horseradish peroxidase-labeled streptavidin
(1:5000, Pierce, Rockford, USA) and the color reaction was developed
using tetramethylbenzidine (TMB) substrate and measured at 450 nm
with reference 630 nm.
OVA-speciﬁc IgA was determined in intestinal lavage ﬂuid as
described above for serumOVA-speciﬁc IgA, except thatmucosal lavage
samples were applied undiluted. Antibody titers were calculated
according to standard dilution series using mouse IgA, IgE, IgG1 and
IgG2a antibodies (BD Biosciences) after subtraction of antibody levels
before the ﬁrst immunization as described before [5].
2.3. Systemic OVA uptake
For measurements of OVA levels in serum samples collected after
OC1, microtiter plates were coated with a mouse anti-OVA capture anti-
body (0.1 μg per well; AbD Serotec) overnight at 4 °C. After washing,Fig. 3.Differences in antigen uptake and clinical responses. After OVA gavage, higher OVA conce
signiﬁcantly elevated in group A after the ﬁrst oral OVA challenge (OC 1). Rectal temperature
responders (triangle) and highly sensitized animals (circles). Data represent mean + SEM; *pwells were blocked with 1% dry milk powder in TBS containing
0.05% Tween for 2 h. Thereafter, serum samples (diluted 1:4) were
added overnight at 4 °C. After repeated washing, a rabbit anti-OVA anti-
body (0.025 μg per well; Thermo Scientiﬁc) was added for 2 h. After
washing, wells were incubated with horseradish peroxidase-labeled
anti-rabbit antibody (1:6000, Thermo Scientiﬁc) and the color reaction
was developed using TMB substrate andmeasured at 450 nmwith refer-
ence 630 nm.2.4. Gastric pH measurements
The efﬁcacy of PPI injections to elevate the gastric pH was evaluated
1 h after i.v. PPI application, as described previously [5]. The pH was
measured on a pH-meter after diluting 150 μL gastric ﬂuids in 1.3 mL
distilled water. As controls, 150 μL 0.9% sodium chloride or 150 μL pH
calibrating solution in distilled water were used.ntrations in serum (A)were found in allergicmice (groupA).MouseMCP-1 levels (B)were
(C) was measured before and 5 and 10 min after i.v. OVA provocation of antibody non-
b 0.05.
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To evaluate allergen-speciﬁc severe clinical responses after OVA
challenges, mouse sera were screened for the mast cell degranulation
marker mMCP-1 using the mouse mMCP-1 ELISA kit (eBioscience,
Vienna, Austria, #88-7503), as described recently [8]. Serum samples
were taken 1 h after PBS challenge (as negative control) and after the
ﬁrst oral OVA challenge (OC1). Hypothermia as a consequence of
systemic anaphylaxis was assessed by measurements of rectal body
temperature before and 5 and 10 min after i.v. OVA challenge.
2.6. Spleen cell stimulation and cytokine measurement
After sacriﬁce, spleens were removed under sterile conditions and
spleen cells were prepared as described [5]. Spleen cells were stained
for CD4+CD25+Foxp3+ T-regulatory cells with the mouse regulatory
T-cell staining kit (eBioscience, #88-8111), according to the manufac-
turer's instructions. Absolute numbers of CD4+T-cells and CD4+CD25+
Foxp3+ T-cells were calculated per spleen.
For cytokine measurements, spleen cells were stimulated with OVA
(0.2 μg per well), medium for 72 h. Undiluted spleen cell supernatants
were screened for cytokine production using the mouse Th1/Th2/Th17/
Th22 13plex FlowCytomix Multiplex kit (eBiosciences, #BMS822FF), fol-
lowingmanufacturer's instructions. Acquisitionwas performedon a FACS
Calibur ﬂow cytometer (BD Biosciences) and data were analyzed using
the eBioscience FlowCytomix Pro Software.
2.7. Histological evaluations of gastro-intestinal tissue sections
Stomach and intestinewere removed under sterile conditions and put
into 4% paraformaldehyde overnight and then transferred into PBS. The
stomach was cut open along the sagittal plane. The intestine was
transversally cut using a randomstart and a cutting interval of 2 cm to ob-
tain systematic uniform random samples. Sections of parafﬁn embedded
samples (3–4 μm thickness) were stained with haematoxylin/eosin (HE)
for inﬂammatory inﬁltrates, periodic acid-Schiff reagent (PAS) for goblet
cells, and chloracetate-esterase (CAE) for detection ofmyeloid cells in the
mucosa as previously described [15].
2.8. Bacterial community composition in feces samples
Ten days before sacriﬁce, feces samples were collected from individ-
ual animals by placing the mouse into a restrainer to avoid cross-
contamination. Feces samples were immediately shock-frozen in liquid
nitrogen and stored at−80 °C until further processing.
About 35 mg of fecal samples per mouse were used for microbiome
analyses. Total bacterial genomic DNA was extracted using NucleoSpin
Kit for Soil (Macherey-Nagel, Dueren, Germany) following themanufac-
turer's instructions. Ampliﬁcation of the V6–V9 region of 16S rRNA gene
was performed with primer 926F (5′-AAACTYAAAKGAATTGACGG-3′)
[16] and 630R (5′-CAKAAAGGAGGTGATCC-3′) [17] with the attached
Roche 454 sequencing adaptors. For multiplexing purposes the forward
primer included a 10-nt barcode sequence. Three independent PCRs
were performed for each sample with Fast Start High Fidelity PCR Sys-
tem (Roche, Mannheim, Germany) containing 20 ng of template DNA
with an optimal annealing temperature of 50 °C and 22 cycles. PCR reac-
tions were pooled and puriﬁed using QiaQuick PCR Puriﬁcation Kit
(Qiagen, Hilden, Germany). After quantiﬁcation using a Quant-iT™
PicoGreen dsDNA quantiﬁcation kit (Invitrogen, Paisley, UK), samples
were equally pooled. The sequencing of this amplicon library was per-
formed on a Roche 454 GS FLX Pyrosequencer (Roche, Mannheim,
Germany) using Titanium chemistry. Ampliconswere sequenced unidi-
rectionally as recommended in the manufacturer's instruction for
amplicon Lib-L libraries. Sequences were processed and data were ana-
lyzed according to the 454 Schloss standard operating procedure (SOP;
http://www.mothur.org/wiki/Schloss_SOP) [18] with the softwareMothur v.1.29.0 [19]. Reads were denoised, quality ﬁltered and
trimmed. For taxonomic analysis, sequences were aligned against Silva
SEED alignment database [20], chimeras were removed using UCHIME
implementation [21] in Mothur, and taxonomic assignment was per-
formed using RDP trainset with a cut-off of 80% [22]. To compare
equal numbers of sequences of each fecal sample, subsamples with
10,429 sequences were generated. Sequences with similarity N97%
were combined to one OTU. Prior to the statistical analysis, all OTUs
with b0.01% of the total abundance were excluded from the analysis.
2.9. Statistical analysis
Data evaluationwas doneusing GraphPadPrism5 software. First, re-
sults were tested for normal distribution followed by unpaired t-test.
Cytokine levels results were analyzed using two-way ANOVA and
Bonferroni multiple comparison test. A p-value b 0.05 was considered
statistically signiﬁcant.
Statistical analysis of gut microbiome data was performed using R
platform (R version 2.15.1) with the packages VEGAN [23] and ade4
[24] and custom R scripts. Hellinger transformed OTU abundances
were used to compare community patterns between the two groups
by Principal Component Analysis (PCA). In addition, amultivariate anal-
ysis of variance (npMANOVA), based on Bray-Curtis distance on relative
OTU abundances was performed. Wilcoxon-Mann Whitney tests were
performed on OTU levels to compare groups N and A. Differences with
an p-value b 0.01 were considered to be statistically signiﬁcant.
3. Theory
Using an inbred mouse strain with all animals housed under identi-
cal conditions and immunized following a standardized protocol, a uni-
form immune response would be expected. Due to different responses
in previous experiments we aimed to retrospectively phenotype ani-
mals, which were protected from food allergy development, and com-
pare them to allergic control animals. This work should establish a
sound basis for further studies to prospectively induce a phenotype
protected from food allergy development, with theﬁnal aim of develop-
ing allergy prevention strategies.
4. Results
4.1. Determination of speciﬁc antibody levels allows classiﬁcation ofmice as
non-responders versus highly sensitized animals
Sixty-four mice were subjected to our protocol of oral food allergy
induction (Fig. 1A). After the last immunization step, 10 out of 64 ani-
mals of interestwere identiﬁed based on lack of OVA-speciﬁc antibodies
(Fig. 1B), i.e. non-responder animals, group N (Fig. 2A–D). They were
compared to 10 control mice (10/64), which mounted high levels of
OVA-speciﬁc IgE (Fig. 2A), IgG1 (Fig. 2B), IgG2a (Fig. 2C) and IgA
(Fig. 2D) responses. These animals were classiﬁed as the highly sensi-
tized, allergic group A. Mice with OVA-speciﬁc IgE below 15 ng/mL
but above background levels, as well as with speciﬁc IgG1 responses
were excluded from further analysis (n = 44).
For read-out of clinical symptoms animals were orally challenged
with OVA twice to induce a strong mucosal response. Systemic OVA
uptake was evaluated in serum samples after oral challenges (Fig. 3A).
We observed higher levels of circulating OVA in the highly sensitized
animals (group A), which might point towards an enhanced intestinal
uptake compared to non-responder animals (group N). Additionally,
mice were subjected to an i.v. OVA provocation to investigate their
potential for a systemic anaphylactic response. Mouse mast cell
protease-1 (mMCP-1) levels, which indicate amast cell-dependent ana-
phylactic response, were measured in serum taken 1 h after PBS and
ﬁrst oral OVA challenge (OC1) (Fig. 3B). We detected only baseline
mMCP-1 levels in challenged non-responders (group N), which were
Fig. 5. Gastric pH measurement after anti-ulcer medication. Acid-suppressive medication
induces comparable elevated intragastric pH levels in all animals. Gastric pH was
measured one hour after i.v. PPI injection on day of sacriﬁce. Data represent mean + SEM.
14 S.C. Diesner et al. / Clinical Immunology 173 (2016) 10–18signiﬁcantly lower as compared to the allergic mice. To ensure the
antigen-speciﬁcity of the anaphylactic response, mice were also chal-
lenged with PBS 10 days before the ﬁrst OVA challenge. Mouse MCP-1
titers were below 10 ng/mL and did not differ between the 2 groups
after oral PBS challenges (data not shown). Additionally, 8/10 mice of
the allergic animals developed a reduction of body temperature, being
deﬁned as a decrease of at least 0.5 °C, measured after oral OVA provo-
cation (data not shown). The temperature drop 5 and 10 min after i.v.
OVA challenge was signiﬁcantly more pronounced in the allergic ani-
mals of group A (Fig. 3C).
4.2. Serological differences are associated with distinct intestinal IgA levels
As a surrogate marker for mucosal humoral defense and potential
protective factor in food allergic responses, total IgA and OVA-speciﬁc
IgA in intestinal lavage ﬂuids of the immunized animalsweremeasured.
Intestinal total (Fig. 4A) and OVA-speciﬁc IgA (Fig. 4B) levels were
signiﬁcantly lower in the non-responders (N) compared to allergic
animals (A).
To rule out thepossibility that thedifferences in antibodyproduction
might be caused by variable responsiveness of mice to the gastric acid-
suppressive effect of PPIs, we performed gastric pH measurements 1 h
after PPI injection. Comparable elevated gastric pH levels were deter-
mined in both groups (Fig. 5).
Sagittal sections of the stomach and transverse, uniform system-
atic random sections of the intestine stained with HE and CAE
for inﬂammatory inﬁltrates, and myeloid mucosal cells, respectively,
showed comparable gastrointestinal morphology between the
groups (Fig. 6).
4.3. IgE responders have stronger Th2 responses, but also higher T-
regulatory cell numbers
To assess whether differences on the antibody level were accompa-
nied by differences in T-regulatory cell subsets, spleen cells were
stained for CD4, CD25 and Foxp3 and analyzed by ﬂow cytometry. No
signiﬁcant differences in total spleen cell numbers were found between
the two groups. The absolute numbers of CD4+ T-cells (Fig. 7A) and
CD4+CD25+Foxp3+ T-regulatory cells (Fig. 7B) were signiﬁcantly
lower in the non-responder animals (N) compared to allergic mice
(A). Cytokine levels were measured in supernatants of spleen cells,
which were stimulated with medium, to investigate the background
levels of cytokine production, or with OVA, to induce an allergen-
speciﬁc cytokine response. In a FlowCytomix multiplex approach, 13
different cytokines were measured (Table 1). In line with the increased
IgE response the Th2 type cytokines IL-4, IL-5 and IL-13 were signiﬁ-
cantly higher after OVA stimulation in the allergic mice than in group
N. No group differences were observed for IL-22, however, this cytokine
was signiﬁcantly elevated within group N when antigen-speciﬁc
splenocyte stimulation was compared to stimulation with mediumFig. 4. IgA levels in intestinal lavage ﬂuid. Total (A) and OVA-speciﬁc IgA (B) were measuredcontrol. Interestingly, the T-regulatory cell associated cytokines IL-10
and IL-27 were higher in the allergic animals (group A) being in line
with the higher numbers of T-reg cells, indicating a counter-
regulatorymechanisms in this group. IL-2 as cytokine for T-cell prolifer-
ation and differentiation was signiﬁcantly elevated in the OVA-
stimulated spleen cells of allergic mice (Table 1).4.4. Bacterial OTU differences in feces samples of non-responder mice and
anaphylactic animals
Feces samples of individual mice were analyzed to identify gut
bacterial community composition. 454-pyrosequencing of the V6-V9
region of the 16S rRNA gene was performed. After quality check and
subsampling, an output of 10,429 sequences per fecal sample was ob-
tained. All sequences with at least 97% similarity were considered as 1
OTU resulting in the detection of 409 OTUs. Principal component analy-
sis (PCA) demonstrated only very limited clustering of OTUs identiﬁed
in the fecal samples of animals within the same group (PCA; Fig. 8A).
npMANOVA analysis was used to compare the group of interest with
the allergic control animals for differences in the bacterial community
composition on OTU level. No signiﬁcant differences could be shown
(p = 0.349). After taxonomic classiﬁcation of sequence data, we did
not detect OTUs of the Porphyromonadaceae family assigned to
Barnesiella (OTU 185) and Tannerella (OTU 213) genus (Fig. 8B
and C) in the non-responders. Therefore, these two OTUs belonging
to the Porphyromonadaceae family were not present in animals
being protected from food allergy. Higher abundances of sequences
showing high similarities to Synthrophaceae (Deltaproteobacteria) and
Ruminococcaceae (Firmicutes, Clostridia) were found in the antibody
non-responder animals (group N) compared to the allergic animals
(group A), where Smithella (OTU 233, Fig. 8D) and Faecalibacterium
(OTU 102, Fig. 8F) were not found and the abundance of Acetivibrio
(OTU 289, Fig. 8E) was signiﬁcantly lower.in intestinal lavage ﬂuid by ELISA. Data represent means + SEM; **p b 0.01, *p b 0.05.
Fig. 6.Histology ofmouse intestines. Representativemicrographs of parafﬁn sections of jejunum stainedwithHE (upper row: apical portion of villi,middle row: basal portion of villi; 1:40)
and CAS staining (bottom row, 1:40) are shown. Left panels for group N and right panels for group A. No signiﬁcant differences were found with respect to epithelium, inﬁltrating
eosinophils and myeloid / mast cells .
15S.C. Diesner et al. / Clinical Immunology 173 (2016) 10–185. Discussion
Food allergy does affect patients' quality of life and represents
an enormous economic burden [25] with major efforts for patients,
their caretakers and regulatory authorities. Therefore, researchers
have focused on identifying underlying mechanisms of food allergyFig. 7. T-regulatory cell subset staining of splenocytes. Signiﬁcantly lower numbers of T-cells ar
(A) and T-reg cells (CD4 + CD25 + Foxp3+) (B) were evaluated by ﬂow cytometry. Data aredevelopment using animal models. Although substantial differences
are known between human and mouse allergic responses, food allergy
mouse models provide important and useful information on disease
mechanisms [26,27]. However, a number of different routes and
protocols of sensitizations has been published so far, rendering direct
comparison of results from studies highly complex [28].e found in spleens of antibody non-responder animals. Absolute numbers of CD4+ T-cells
mean + SEM; *p b 0.05.
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16 S.C. Diesner et al. / Clinical Immunology 173 (2016) 10–18The advantage of our oral food allergy model in BALB/c mice is the
physiological sensitization route applying the allergen intragastrically
under acid suppressive medication without further adjuvants [5]. Even
though in our animal experiments inbred mice were housed and sensi-
tized under identical conditions, immune responses were not uniform
[4–7,9,10,29–32] (and own unpublished data). Thus, in the present
study we aimed to phenotype mice being protected from food allergy
in comparison to mice being highly sensitized and anaphylactic after
immunizations.
Based on this retrospective approach, we identiﬁed 3 distinct fea-
tures of animals protected from food allergy development: 1) a tight in-
testinal epithelium, 2) elevated levels of IL-22 and3) a distinctmicrobial
composition.
The integrity of the intestinal epithelium is one of the ﬁrst major
regulatory mechanisms against the development of food allergy. A
“leaky gut”, meaning the damage of the epithelial barrier function and
an increased uptake of food antigens and allergens into the system,
can facilitate allergic responses if other local pro-inﬂammatory signals
are present. In our model we observed signiﬁcantly lower serum con-
centrations of orally applied OVA only in the animals protected from
food allergy, which might indirectly point towards a lower uptake of
the allergen via the mucosa. Functional intestinal epithelial integrity
has been linked to secretory immunity as mice deﬁcient for sIgA and
IgM have increased mucosal leakiness [33,34]. In general, mucosal IgA
is important for the immunological defense against exogenous antigens
and pathogens by exclusion, and thus, might be protective and lead to
mucosal tolerance [35]. Some studies revealed tolerant mice to have
more secretory IgA than sensitized animals [36]. However, also in
mice deﬁcient for the polymeric immunoglobulin receptor, and thus
lacking secretory IgA, oral tolerance can be induced. This observation
led to the conclusion that IgA is probably not the only control mecha-
nism of oral tolerance [37,38]. In contrast, a recent study using a cholera
toxin-basedmousemodel of cow's milk allergy revealed high IgA levels
in plasma and colon homogenates upon a 6weeks immunization proto-
col [39]. Itmight behypothesized that in food allergy increased amounts
of allergen-speciﬁc IgA are secreted into the intestine as counter
mechanism to avoid intestinal allergen uptake or as a result of the
overall enhanced immune response, which might be the explanation
for the observed higher local and systemic IgA levels in allergic mice
in our food allergy model.
In addition to the local secretory immune differences we observed
changes in intestinal bacterial colonization patterns between the groups.
Although inbred animals were housed and treated identically, non-
allergic animals (group N) revealed signiﬁcantly higher abundances of
sequences belonging to Synthrophaceae (Deltaproteobacteria) and
Ruminococcaceae (Firmicutes, Clostridia), whereas two OTUs of the
Porphyromonadaceae family were more abundantly present only in aller-
gic animals (groupA). Variations in gutmicrobiota are associatedwith the
induction of several diseases, including diabetes, obesity and cancer [40]
and were strongly linked to the development of atopic disorders [41], in-
cluding food allergy [42]. In line with the hygiene hypothesis [43], a
reduced or altered microbial load may insufﬁciently counterbalance a
Th2 response thus favouring the occurrence of food allergy [44]. In
mice, it appears that even minor differences in the gut microbiome can
have substantial effects on experimental models of disease. Inbred mice
with the same genetic background obtained from two different suppliers
featured different dominant microbial communities [45]. Changes in mi-
crobial compositionwere further induced by variations of diet, bymoving
young mice from one room to another or by stress [40,46]. Therefore, in-
consistencies within animal experiments may be related to the observed
differences in the bacterial composition. In our mouse model, animals
were obtained from the same supplier. Offspring of different mothers
were randomly grouped and were all fed the same OVA-free diet.
Interestingly, Tannerella forsythensis and Porphyromonas gingivalis, both
belonging to the Porphyromonadaceae family,whichwaspresent at signif-
icantly higher levels in allergicmice in our study,were shown to stimulate
Fig. 8.Analysis of bacterial community composition ofmurine feces samples of non-responder (N) and allergic (A)mouse groups. Hellinger transformed sequence abundance data onOTU
levelswere analyzed by principal component analysis (A). Relative abundances of Barnesiella (OTU 185; B), Tannerella (OTU 213; C), Smithella (OTU 233; D), Acetivibrium (OTU289, E) and
Faecalibacterium (OTU 102; F) are shown in boxplot analyses for each group N and A. The boxes represent the inner quartile value range with the median indicated as black line.
17S.C. Diesner et al. / Clinical Immunology 173 (2016) 10–18a strong pro-inﬂammatory epithelial immune response under anaerobic
conditions [47]. With regard to food allergy, the Porphyromonadaceae
family was also found in OVA sensitized Il4raF709 mice together with
Rikenellaceae species, to discriminate between OVA sensitized and PBS
sensitized mice [48].
Moreover, Ruminococcaceae, belonging to the system of Clostridiales,
might be linked to IL-22, as Clostridia-containing microbiota protected
against sensitization to food allergens and induced IL-22 [49], which
has been characterized for its protective and inﬂammatory functions
and its regulatory role on intestinal epithelial integrity [50,51]. In line
with these results we observed higher levels of IL22 after OVA stimula-
tion of spleen cells in tolerant mice, which had higher abundances of
Ruminococcaceae, compared to allergic animals. However, at this point
it can only be speculated whether the OTUs more abundantly present
in the tolerant group can explain the non-responsiveness of these ani-
mals. As we collected feces samples only shortly before sacriﬁce, it is
not possible to draw conclusions on bacterial composition before and
during food allergy development. We do not know at this point whether
the signiﬁcantly more abundant OTUs were found in the respective ani-
mals already before sensitization and, therefore, had a direct inﬂuence on
thedevelopment of the immune response, orwhether the suppression of
these OTUs occurred as a result of the immunization process and had an
indirect effect on the sensitization.
In conclusion, our food allergy animal model likely reﬂects the situ-
ation in human patients. By phenotyping animals being protected from
food allergy we determined a reduced uptake of OVA, presumably due
to a tighter epithelium, elevated allergen-speciﬁc IL-22 levels and ab-
sence or higher abundance of distinct bacterial strains to be associated
with allergy protection.Without any doubt, it will be essential for future
studies to evaluate whether changes of microbiota composition as
observed in this retrospective evaluation can prospectively achieve
induction of a phenotype protected from food allergy development.Conﬂict of interest
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